Cooley advised Reka on the fundraising. Reka announced its funding of $58 million dollars led by DST Global Partners and founding investor Radical Ventures along with participation from...
You must be a Standard 1 Year member to access this content.
Cooley is acting as legal counsel to Veritone, and Sidley Austin is acting as legal counsel to Career Builder. Veritone, Inc. (NASDAQ: VERI) announced its agreement...
You must be a Standard 1 Year member to access this content.
Cooley advised SCYNEXIS on the deal. SCYNEXIS announced its exclusive license agreement with GSK for Brexafemme. The exclusive license agreement gives GSK rights to commercialize SCYNEXIS’ ibrexafungerp...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
You must be a Standard 1 Year member to access this content.
